WB: 0.2-2 µg/mL, FC: 0.5-2 µg/sample Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
Lot specific
Buffer
POLR2 G antibody in PBS (3.0 mM KCl, 1.5 mM KH2 PO4 , 140 mM NaCl, 8.0 mM Na2 HPO4 (pH 7.4)) containing 1 % bovine serum albumin (BSA) and 0.05 % sodium azide (NaN3 ).
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handhabung
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 2-8 °C for up to one year. We recommend long term storage at -20 °C.
Target
POLR2G
(Polymerase (RNA) II (DNA Directed) Polypeptide G (POLR2G))
RPB19 antikoerper, RPB7 antikoerper, hRPB19 antikoerper, hsRPB7 antikoerper, Rpb7 antikoerper, POLR2G antikoerper, 2410046K11Rik antikoerper, A230108L04Rik antikoerper, C76415 antikoerper, RBP7 antikoerper, Rpo2-7l antikoerper, RNA polymerase II subunit G antikoerper, polymerase (RNA) II (DNA directed) polypeptide G antikoerper, polymerase (RNA) II (DNA directed) polypeptide G L homeolog antikoerper, POLR2G antikoerper, Polr2g antikoerper, polr2g antikoerper, polr2g.L antikoerper
Hintergrund
The homeodomain-containing transcription factor NKX3A is a putative prostate tumor suppressor that is expressed in a largely prostate-specific and androgen-regulated manner. Loss of NKX3A protein expression is a common finding in human prostate carcinomas and prostatic intraepithelial neoplasia. Synonyms: Monoclonal POLR2G antibody, Anti-POLR2G antibody, RNA polymerase II subunit B7 antibody, RPB7 antibody, hRPB19 antibody, hsRPB7 antibody, MGC138367 antibody, MGC138369 antibody.